A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

Boston, USA-based Newleos Therapeutics, a neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug ...

For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the ...

Blue Oak has been operating largely under the radar since it was set up in 2016, but has quietly started building alliances as it prepares to advance new drug classes for central nervous system ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...

A special court for the Control of Narcotic Substances (CNS) in Taxila on Thursday sentenced nine years of imprisonment to an ...

Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...